Dexcom
About Dexcom
Dexcom Corporation, listed on NASDAQ under the ticker DXCM, pioneers continuous glucose monitoring (CGM) technology that transforms diabetes care worldwide. Founded in 1999, the company has grown from a small startup to a multinational health‑tech organization with over 2,000 employees and a presence in more than 20 countries. Dexcom’s core products combine wearable sensors, cloud‑based analytics, and mobile applications to provide real‑time glucose insights, helping patients and clinicians make informed decisions. The firm invests heavily in research and development, expanding its portfolio beyond diabetes to broader health monitoring solutions. Known for a culture of innovation, collaboration, and patient‑centric focus, Dexcom offers employees opportunities to work on cutting‑edge medical devices, engage in global projects, and benefit from continuous learning programs. The company emphasizes diversity, inclusion, and community impact, fostering an environment where engineers, data scientists, and healthcare professionals can together improve health outcomes.